Ultragenyx to Host Conference Call for Third Quarter 2025 Financial Results and Corporate Update
(NASDAQ:RARE), NOVATO, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Tuesday, November 4, 2025, to discuss its financial […]